Related Experiment Videos

[Familial hyperhomocysteinemia with early development of atherosclerosis]

T B Domagała1, M Libura, H Gozdecka

  • 1II Katedry Chorób Wewnetrznych Collegium Medicum UJ w Krakowie.

Insights

This study identifies hyperhomocysteinemia in a Polish family, linked to early coronary disease. Folic acid and vitamin B12 treatment effectively lowered homocysteine levels.

Area of Science:

  • Genetics and Cardiovascular Medicine
  • Metabolic Disorders Research

Background:

  • Hyperhomocysteinemia is a risk factor for cardiovascular disease.
  • Familial hyperhomocysteinemia can lead to early-onset coronary complaints and myocardial infarction.

Observation:

  • A large Polish family spanning 4 generations exhibited hyperhomocysteinemia.
  • The proband experienced coronary issues at age 20 and myocardial infarction by 50.
  • Affected individuals showed elevated plasma homocysteine levels, with some displaying abnormalities during methionine loading tests.

Findings:

  • Two daughters of the proband were diagnosed with hyperhomocysteinemia.
  • Enzyme levels for cystathionine beta-synthase and methylenetetrahydrofolate reductase were normal.
  • Treatment with folic acid and vitamin B12 significantly reduced plasma homocysteine levels.

Implications:

  • This is the first reported family with hyperhomocysteinemia in Poland.
  • Early detection and intervention with B vitamins can manage hyperhomocysteinemia and mitigate cardiovascular risks.
  • Understanding genetic predispositions to hyperhomocysteinemia is crucial for preventative cardiology.

Related Concept Videos